acebutolol has been researched along with Chromosome Deletion in 2 studies
Acebutolol: A cardioselective beta-1 adrenergic antagonist with little effect on the bronchial receptors. The drug has stabilizing and quinidine-like effects on cardiac rhythm, as well as weak inherent sympathomimetic action.
acebutolol : An ether that is the 2-acetyl-4-(butanoylamino)phenyl ether of the primary hydroxy group of 3-(propan-2-ylamino)propane-1,2-diol.
Chromosome Deletion: Actual loss of portion of a chromosome.
| Excerpt | Relevance | Reference |
|---|---|---|
| "This report describes the case of a 4-year-old boy diagnosed with Smith-Magenis syndrome in whom treatment with a beta(1)-adrenergic antagonist in the morning (to suppress the diurnal melatonin secretion) and melatonin in the evening (to generate a nocturnal peak of melatonin) improved his sleep quality, evaluated by polysomnographic studies." | 7.73 | Smith-Magenis syndrome: a case report of improved sleep after treatment with beta1-adrenergic antagonists and melatonin. ( Abad, A; Carpizo, R; González, M; Martínez, A; Mediavilla, D; Sánchez-Barceló, EJ, 2006) |
| "This report describes the case of a 4-year-old boy diagnosed with Smith-Magenis syndrome in whom treatment with a beta(1)-adrenergic antagonist in the morning (to suppress the diurnal melatonin secretion) and melatonin in the evening (to generate a nocturnal peak of melatonin) improved his sleep quality, evaluated by polysomnographic studies." | 3.73 | Smith-Magenis syndrome: a case report of improved sleep after treatment with beta1-adrenergic antagonists and melatonin. ( Abad, A; Carpizo, R; González, M; Martínez, A; Mediavilla, D; Sánchez-Barceló, EJ, 2006) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Nijim, Y | 1 |
| Adawi, A | 1 |
| Bisharat, B | 1 |
| Bowirrat, A | 1 |
| Carpizo, R | 1 |
| Martínez, A | 1 |
| Mediavilla, D | 1 |
| González, M | 1 |
| Abad, A | 1 |
| Sánchez-Barceló, EJ | 1 |
2 other studies available for acebutolol and Chromosome Deletion
| Article | Year |
|---|---|
First Case Report of Smith-Magenis Syndrome (SMS) Among the Arab Community in Nazareth: View and Overview.
Topics: Acebutolol; Adrenergic beta-1 Receptor Antagonists; Antioxidants; Arabs; Chromosome Deletion; Drug C | 2016 |
Smith-Magenis syndrome: a case report of improved sleep after treatment with beta1-adrenergic antagonists and melatonin.
Topics: Acebutolol; Adrenergic beta-Antagonists; Antioxidants; Child, Preschool; Chromosome Deletion; Chromo | 2006 |